We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Agent Helps Nerves Grow in Damaged Spinal Cords

By Biotechdaily staff writers
Posted on 18 Mar 2004
A study has found that infusing an anti-scarring agent called decorin into the damaged spinal cords of rats can suppress molecules that block nerve regeneration after spinal cord injury. The results were published in the March 8, 2004, issue of the European Journal of Neuroscience.

Misaligned scar tissue that forms at the site of spinal cord injuries can physically block nerve regeneration and contains molecules called chondroitin sulfate proteoglycans that inhibit the growth of nerve fibers. Decorin inhibits the action of these inflammatory molecules, called transforming growth factors.
The researchers infused decorin into the injury site in rates with a mini-pump, which used tiny silica cannulas so small they did not contribute to the formation of scar tissue. Using a laser scanning microscope and protein chemistry to analyze tissue samples, the researchers were able to show that the infusion reduced inflammation, scar formation, and the levels of some proteoglycans by 80-95%, allowing new nerve fibers to grow across spinal cord injuries in only four days.

"We have found a promising new approach to control inflammation and scar formation, which will be an important part of future strategies to encourage axon regeneration and recovery after spinal cord injury,” said lead author Dr. Stephen Davies, assistant professor of neurosurgery and neurosciences at the Baylor College of Medicine (Houston, TX, USA).

The decorin used in the study was a genetically engineered form of human decorin developed by The Institute for Rehabilitation and Research, Integra LifeSciences, The Burnham Institute, and GTC Biotherapeutics, Inc.




Related Links:
Baylor College of Medicine

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Repetitive Pipette
VWR® Stepper Pro
New
Manual Pipetting Aid
Pipette Controllers macro

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
18 Mar 2004  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
18 Mar 2004  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
18 Mar 2004  |   BioResearch